Trichophyton mentagrophytes, genotype VII (TMVII), has been recognized as a fungal infection of concern in the United States since 2024. Transmission has been associated with skin-to-skin contact similar to sexually transmitted infections (STIs) that can also present with a rash. Recognizing TMVII and initiating systemic treatment promptly are key to reducing the transmission of TMVII. The National Network of Prevention Training Centers, in collaboration with the Centers for Disease Control and Prevention and the Minnesota Department of Health, invites you to attend this timely national webinar on TMVII. Learn the basics of recognizing and assessing TMVII, evidence-based recommendations for therapy, and updates on the prevalence and incidence of TMVII in the United States. This webinar will feature expert guidance from leading voices in infectious disease and will include time for questions and answers.
As a result of this activity, the learner will be able to identify at least two key considerations in the recognition, assessment, and management of tricophyton mentagorphytes, genotype VII (TMVII).
Date: 1/29/2026
Time: 9:00-10:15 AM PST, 10:00-11:15 AM MST, 11:00-12:15 PM CST, 12:00-12:15 PM EST
Location: A Zoom link will be sent in the confirmation email after registration.
-
Nexi Sanchez
nexi.sanchezvillalobos@dhha.org